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Abstract
 
Signal transducer and activator of transcription (Stat)4 and Stat6 are transcription factors that
provide type 1 and type 2 response, respectively. Here, we explored the role of Stat4 and Stat6
 
in innate immunity during septic peritonitis. Stat4
 
2
 
/
 
2
 
 and Stat6
 
2
 
/
 
2
 
 mice were resistant to the
lethality compared with wild-type (WT) mice. At the mechanistic level, bacterial levels in
Stat6
 
2
 
/
 
2
 
 mice were much lower than in WT mice, which was associated with increased peri-
 
toneal levels of interleukin (IL)-12, tumor necrosis factor (TNF)-
 
a
 
, macrophage-derived
chemokine (MDC), and C10, known to enhance bacterial clearance. In Stat4
 
2
 
/
 
2
 
 mice, he-
patic inflammation and injury during sepsis were significantly ameliorated without affecting
local responses. This event was associated with increased hepatic levels of IL-10 and IL-13,
while decreasing those of macrophage inflammatory protein (MIP)-2 and KC. Sepsis-induced
renal injury was also abrogated in Stat4
 
2
 
/
 
2
 
 mice, which was accompanied by decreased renal
levels of MIP-2 and KC without altering IL-10 and IL-13 levels. Thus, Stat6
 
2
 
/
 
2
 
 and Stat4
 
2
 
/
 
2
 
mice appeared to be resistant to septic peritonitis by enhancing local bacterial clearance and
modulating systemic organ damage, respectively, via balancing cytokine responses. These re-
sults clearly highlight an important role of local type 1 and systemic type 2 cytokine response
in protective immunity during sepsis, which can be regulated by Stat proteins.
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Introduction
 
Sepsis is a severe infection in the body and bloodstream
that commonly originates in the lung, urinary tract, and ab-
domen (1, 2). Although the overall mortality rate of sepsis
 
is 
 
z
 
25–35%, patients with septic peritonitis have a higher
mortality rate, reaching 60–80% (3). Septic peritonitis is
characterized by a massive leukocyte infiltration into the
peritoneum, where these cells are the first line of defense
for clearing microorganisms (4, 5). However, once the host
fails to restrict microbes to a local area, microbes may in-
vade into the bloodstream and their products trigger an
overwhelming systemic response via the overzealous pro-
duction of inflammatory mediators including cytokines,
 
leading to shock or multiple organ failure (MOF)
 
1
 
 (6).
 
The immune response is generally divided into two types,
termed type 1 and type 2 responses, based on the distinct cy-
tokine secretion patterns (7). Although the type 1 cytokine
response is essentially important in host defense to bacterial
infection (8), the type 2 cytokine response also appears to
play a protective role when microbes have disseminated into
the body. In a murine model of septic peritonitis, we have
shown that IL-12 (type 1 promoting cytokine) detected in
the peritoneum is beneficial to clear bacteria from the peri-
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Abbreviations used in this paper: 
 
AST, aspartate transaminase; ALT, alanine
transaminase; BUN, blood urea nitrogen; CLP, cecal ligation and punc-
ture; MDC, macrophage-derived chemokine; MIP, macrophage inflam-
matory protein; MPO, myeloperoxidase; MOF, multiple organ failure;
Stat, signal transducer and activator of transcription; WT, wild-type. 
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toneum (9), while IL-13 (a type 2 cytokine) detected specif-
ically in organs, functions as an immunomodulator of sys-
temic organ failure (10). Thus, mice with septic peritonitis
exhibit a mixed type 1 and type 2 cytokine response, leading
to our hypothesis that a balanced type 1/type 2 cytokine re-
sponse may be critical in host defense during sepsis.
Signal transducer and activator of transcription (Stat)
proteins are transcription factors that provide a direct link
between the cytokine receptors and cytokine-induced gene
transcription (11). Stat4 and Stat6 are members of this fam-
ily that are essential in mediating responses to IL-12 and
IL-13, respectively (11, 12). In the present study, we em-
ployed mice deficient in Stat4 or Stat6 gene (Stat4
 
2
 
/
 
2
 
 or
Stat6
 
2
 
/
 
2
 
), and further examined the contribution and regu-
lation of type 1 and type 2 cytokine response during sepsis
induced by cecal ligation and puncture (CLP), which pos-
sesses several hallmarks of clinical sepsis with peritonitis as-
sociated with postsurgical or accidental trauma (13). Since
IL-12 and IL-13 are important in host defense during CLP-
induced sepsis by enhancing bacterial clearance and modu-
lating organ damage, respectively (9, 10), we hypothesized
that both Stat4
 
2
 
/
 
2
 
 and Stat6
 
2
 
/
 
2
 
 mice would be susceptible
to CLP because of an impaired bacterial clearance and se-
vere organ damage, respectively. Alternatively, a possible
reduction in organ damage in Stat4
 
2
 
/
 
2
 
 mice and an in-
crease in bacterial clearance in Stat6
 
2
 
/
 
2
 
 mice may result in
an improved survival of these mice after CLP. In this study,
we have shown that both Stat4
 
2
 
/
 
2
 
 and Stat6
 
2
 
/
 
2
 
 mice are
resistant to the lethality initiated by CLP, by balancing the
local (peritoneal) and systemic (organ-associated) cytokine
responses. The results clearly highlight an important pro-
tective role of the local type 1 cytokine and the systemic
type 2 cytokine response in innate immunity during sepsis,
which is regulated by Stat proteins.
 
Materials and Methods
 
Mice.
 
Stat4
 
2
 
/
 
2
 
 and Stat6
 
2
 
/
 
2
 
 mice were generated as de-
scribed previously (14, 15), backcrossed 10 generations to BALB/c
mice, and maintained in the Indiana University Laboratory An-
imal Resource Center, and then transferred to the animal care fa-
cility unit at the University of Michigan. Female Stat4
 
2
 
/
 
2
 
 and
Stat6
 
2
 
/
 
2
 
 mice (6–8 wk of age) were used in this study. Age- and
sex-matched BALB/c mice were purchased from The Jackson
Laboratory. All mice were housed for at least 7 d before manipu-
lations under specific pathogen-free conditions. The Animal Use
Committee at the University of Michigan approved all studies.
 
CLP. 
 
The mice underwent CLP surgery as described previ-
ously (13). In brief, the mice were anesthetized with intraperito-
neal injection of sodium pentobarbital (Veterinary Laboratories,
Inc.), followed by ketamine HCL (Vetamine; Mallinckrodt Vet-
erinary, Inc.). Under sterile conditions, the cecum was exposed
through a 1-cm incision of the lower left abdomen, ligated with a
3-0 silk suture below the ileocecal valve, and punctured through
once with a 21-gauge needle. The cecum was replaced in the
peritoneum and the abdomen was closed with surgical staples.
The mice were injected with 1 ml of saline subcutaneously for
fluid resuscitation, and placed on a heating pad until they recov-
ered from anesthesia.
 
Experimental Protocol. 
 
In the first set of experiments, survival
rates of Stat4
 
2
 
/
 
2
 
, Stat6
 
2
 
/
 
2
 
, and wild-type (WT) mice were mon-
itored for 14 d after CLP. In the next set of experiments, the
CLP mice were anesthetized, bled, and killed at appropriate in-
tervals after CLP. The peritoneal cavities were washed with 2 ml
of sterile saline, and the lavage fluids were harvested under sterile
conditions. After taking a 10-
 
m
 
l aliquot of lavage fluids for assess-
ment of bacteria CFU, the fluids were centrifuged at 6,000 
 
g
 
 for 1
min at 4
 
8
 
C and cell-free peritoneal fluids were stored at 
 
2
 
20
 
8
 
C.
Cell pellets were resuspended in saline and the cell numbers were
counted in a hemocytometer. Differential cell analysis was made
after Diff-Quik staining of the smear slides (Dade AG). The liver,
lung, and kidney were excised, weighed, snap frozen in liquid ni-
trogen, and stored at 
 
2
 
20
 
8
 
C for subsequent analyses. A part of
tissues was fixed in 4% paraformaldehyde, embedded in paraffin,
and the tissue sections were stained with hematoxylin and eosin.
In other experiments, passive neutralization of TNF-
 
a
 
 or IL-12
was carried out by intraperitoneal injection of 0.5 ml of neutraliz-
ing anti–murine TNF-
 
a 
 
antiserum or anti–murine IL-12 antise-
rum, 2 h before CLP. The antibodies did not cross-react with sev-
eral other murine cytokines. As a control, 0.5 ml of preimmune
serum was used. The endotoxin content in these sera was below
detection level (
 
,
 
0.05 EU/ml, Pyrogent; BioWhittaker).
 
Determination of CFU.
 
10 
 
m
 
l of peritoneal lavage fluids and
peripheral blood from each mouse was placed on ice and serially
diluted with sterile saline. 10 
 
m
 
l of each dilution was aseptically
plated on tryptose soy agar (TSA) blood agar plates (Difco Labo-
ratories) and incubated overnight at 37
 
8
 
C, after which the num-
ber of colonies was counted. Data were expressed as CFU/10 
 
m
 
l.
 
Clinical Chemistry.
 
Serum levels of aspartate transaminase
(AST), alanine transaminase (ALT), blood urea nitrogen (BUN),
and creatinine were measured by Clinical Pathology at the Uni-
versity of Michigan Medical School using standardized techniques.
 
Measurement of Cytokines and Myeloperoxidase.
 
The protein
concentrations of murine TNF-
 
a
 
, IFN-
 
g
 
, IL-4, IL-10, IL-12,
IL-13, macrophage inflammatory protein (MIP)-2, KC, mac-
rophage-derived chemokine (MDC), and C10 were measured by
specific ELISAs, as described previously (10, 16, 17). The ELISAs
employed in this study did not cross-react with other murine cy-
tokines, and consistently detected murine cytokine concentra-
tions 
 
.
 
25 pg/ml. Myeloperoxidase (MPO) in tissue extracts was
measured by ELISA kit (Calbiochem-Novabiochem) according
to the manufacturer’s instruction. The lower detection limit was
1.6 ng/ml.
 
Preparation of Organ Extracts.
 
0.1 g of excised organs was
placed in 1 ml of PBS containing complete protease inhibitor
(Roche Diagnostics), and homogenized with a Tissue Tearor
(model 985-370; Biospec Products, Inc.). The homogenates sub-
sequently received freeze–thaw extraction once for ELISA and
twice for MPO assay. The homogenates were centrifuged at
6,000 
 
g
 
 for 20 min at 4
 
8
 
C, and the cleared supernatants were used
for measurement of cytokines or MPO. Protein concentration in
the supernatants was measured by protein dye binding assay (pro-
tein assay; Bio-Rad Laboratories). The levels of cytokines and
MPO in organ extracts were expressed as nanogram per milli-
gram of protein.
 
Measurement of Lysozomal Enzyme Release and Superoxide Produc-
tion.
 
The lysozomal enzyme release from cells was determined
by 
 
b
 
-glucuronidase activity in the culture supernatants, according
to the methods described previously (18). Peritoneal macro-
phages were harvested from untreated mice. Peripheral neutro-
phils (
 
.
 
94%) were isolated from heparinized mice blood by dex-
tran sedimentation, followed by Ficoll gradient centrifugation and 
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hypotonic lysis of erythrocytes. Cells (10
 
6
 
 ) were suspended in an-
tibiotics-free RPMI 1640 containing 5% FCS, cultured in 24-
well dishes with 
 
Escherichia coli
 
, LPS (100 
 
m
 
g/ml; Sigma-Aldrich),
or 10
 
6
 
 CFU of 
 
E. coli
 
 recovered from the peritoneum after CLP,
incubated overnight at 37°C, and the cleared supernatants were
assayed.
The superoxide production from cells was measured using the
reduction of ferricytochrome c (19). In brief, cells (10
 
6
 
) were cul-
tured in Phenol red–free RPMI 1640 containing cytochrome c
(1.3 mg/ml; Sigma-Aldrich), stimulated with LPS or 
 
E. coli
 
 for 30
min, and the supernatants were measured spectrophotometrically
at 550 nm as a function of ferricytochrome c reduction.
 
Statistics.
 
Statistical significance was evaluated by analysis of
variance. In case of survival curve and CFU count, the data were
analyzed by the log-rank test and Mann-Whitney test, respec-
tively. A 
 
P
 
 ,
 
 0.05 value was regarded as statistically significant.
All data were expressed as mean 
 
6
 
 SEM.
 
Results
 
Stat4
 
2
 
/
 
2
 
 and Stat6
 
2
 
/
 
2
 
 Mice Were Resistant to CLP-induced
Lethality.
 
To evaluate the contribution of Stat4 and Stat6
in sepsis induced by CLP, initial studies were carried out
to determine the survival rates in Stat4
 
2
 
/
 
2
 
, Stat6
 
2
 
/
 
2
 
, and
WT mice after CLP. As shown in Fig. 1, survival rates in
Stat4
 
2
 
/
 
2
 
 and Stat6
 
2
 
/
 
2
 
 mice were significantly higher than
in WT mice. On day 2, the survival rate in Stat4
 
2
 
/
 
2
 
 and
Stat6
 
2
 
/
 
2
 
 mice was 87.5% (21/24 mice) and 88.0% (22/25
mice), respectively, but 33.3% (8/24 mice) in WT mice.
All WT mice died by day 5 while 41.7% (10/24 mice) and
24% (6/25 mice) of Stat4
 
2
 
/
 
2
 
 and Stat6
 
2
 
/
 
2
 
 mice, respec-
tively, were alive on the same day (Fig. 1). There were no
statistical differences in the survival curves between
Stat4
 
2
 
/
 
2
 
 and Stat6
 
2
 
/
 
2
 
 mice. These data clearly indicate
that both Stat4
 
2
 
/
 
2
 
 and Stat62/2 mice are resistant to the
lethality induced by CLP.
Bacterial Clearance and Neutrophil Influx Were Augmented in
Stat62/2 Mice, but Not in Stat42/2 Mice. In an attempt to
identify the mechanism whereby Stat42/2 and Stat62/2
mice were resistant to CLP, we first examined the bacterial
load in the peritoneal fluids and blood of mice after CLP.
No bacteria were recovered from the peritoneum and
blood of untreated WT, Stat42/2, and Stat62/2 mice. The
peritoneal fluids at 24 h after CLP in WT mice contained a
significant number of bacteria in the peritoneum (Fig. 2).
At this time point, the bacterial load in the peritoneum
in Stat42/2 mice was similar to WT mice. All WT and
Stat42/2 mice contained bacteria in the peritoneum. In
Stat62/2 mice, however, only 1 out of 11 mice contained
bacteria in the peritoneum. Consequently, the mean peri-
toneal CFU in Stat62/2 mice was 10-fold lower than in
WT mice (Fig. 2). Likewise, the bacterial load recovered
from peripheral blood in Stat62/2 mice was lower than that
in WT or Stat42/2 mice, although it was not statistically
significant (Fig. 2). Thus, Stat62/2 mice exhibited the ca-
pacity to localize the infection within the peritoneal cavity.
CLP induces a rapid leukocyte infiltration in the perito-
neum directed at eliminating bacteria from the peritoneum
(13, 20). Experiments were next conducted to assess the
numbers of leukocyte populations in the peritoneum after
CLP. The number of resident leukocytes in the perito-
Figure 1. Stat42/2 and Stat62/2 are resistant to CLP-induced lethality.
The survival rates in Stat42/2 (24 mice), Stat62/2 (25 mice), and WT
mice (24 mice) were monitored for 14 d after CLP. Two different exper-
iments were carried out, and the data were pooled. The mortality rates
were very similar in individual experiments. There is a statistically signifi-
cant difference between WT and Stat42/2 or Stat62/2 mice (log-rank
test). *P , 0.0001 compared with WT.
Figure 2. Stat62/2 mice, but not Stat42/2 mice, clear bacteria more ef-
fectively than WT mice. At 24 h after CLP (WT, 10 mice; Stat42/2, 9
mice; Stat62/2, 11 mice), mice were killed, and the peritoneal fluids and
sera were harvested. 10 ml of peritoneal fluids and blood was serially di-
luted and plated on TSA blood agar plates. Line represents median CFU
count. ‡P , 0.001 compared with WT mice.682 Stat4 and Stat6 in Innate Immunity
neum (.98% macrophages) was similar between WT,
Stat42/2, and Stat62/2 mice (Fig. 3). There were no differ-
ences in the numbers of infiltrating neutrophils and mac-
rophages between WT and Stat42/2 mice. However, the
number of neutrophils at 6 h after CLP in Stat62/2 mice
was significantly increased compared with WT mice (Fig.
3). The leukocyte activation was also assessed in vitro, by
measuring b-glucuronidase release (a lysozomal enzyme)
and superoxide anion (O2
2) generation (an NADPH-
dependent oxidase enzyme) from neutrophils and mac-
rophages after the stimulation with LPS or E. coli. Conse-
quently, there were no differences in the levels of these
enzymes between WT and Stat42/2 or Stat62/2 mice, sug-
gesting that the activation of leukocytes by LPS or E. coli in
itself is independent of Stat4 and Stat6. Thus, Stat62/2
mice, but not Stat42/2 mice, cleared bacteria more effec-
tively than WT mice, an event that was accompanied by an
increase in the number of neutrophils in the peritoneum of
Stat62/2 mice, but was not directly associated with the
function of innate immune cells.
Peritoneal Levels of IL-12, TNF-a, MDC, and C10 Were
Augmented in Stat62/2 Mice. To examine the mechanism
underlying the increased bacterial clearance and neutrophil
infiltration in Stat62/2 mice, peritoneal levels of cytokines
in Stat62/2 mice were then measured and compared with
those in WT mice. Interestingly, the level of IL-12 in
Stat62/2 mice at 6 h after CLP was significantly higher than
in WT mice (Fig. 4), although IFN-g level was not aug-
mented in Stat62/2 mice (data not shown). The levels of
TNF-a were increased in Stat62/2 mice compared with
WT mice (Fig. 4). When TNF-a, but not IL-12, was neu-
tralized with its antibodies, the neutrophil influx at 6 h after
CLP in Stat62/2 mice was significantly reduced compared
with control antibodies (Fig. 5 A), suggesting that aug-
mented TNF-a in Stat62/2 mice was responsible for the
increased number of neutrophils in Stat62/2 mice. The
bacterial load in the peritoneum of Stat62/2 mice was in-
creased by either anti–TNF-a or anti–IL-12 treatment
compared with control (Fig. 5 B), indicating that elevated
levels of IL-12 and TNF-a contribute to the improved
bacterial clearance in Stat62/2 mice. MDC levels at 6 h af-
ter CLP were dramatically increased while decreasing at
24 h, suggesting that the production kinetics of MDC was
altered in Stat62/2 mice. In addition, C10 levels after CLP
were increased in Stat62/2 mice compared with WT mice
(Fig. 4). CC chemokines MDC and C10 are shown to en-
Figure 3. The leukocyte infiltration in the peritoneum after CLP. At 0,
6, and 24 h after CLP, mice were killed and the infiltrating leukocytes in
the peritoneal cavity were harvested. The numbers of total leukocytes,
neutrophils, and macrophages were then counted. Each point represents
the mean 6 SEM of 7–11 estimations from separate mice. †P , 0.05,
§P , 0.01 compared with WT mice.
Figure 4. Stat62/2 mice augment the production of IL-12 and TNF-a,
MDC, and C10 in the peritoneum after CLP. At 6 and 24 h after CLP,
mice were killed, bled, and the peritoneal fluids were harvested. The pro-
tein concentrations of IL-12, TNF-a, MDC, and C10 were measured by
ELISA. The data represent the mean 6 SEM of 8–11 estimations from
separate mice. †P , 0.05, §P , 0.01, ‡P , 0.001, *P , 0.0001 compared
with WT mice. Cytokines harvested from normal mice were below de-
tection level.683 Matsukawa et al.
hance bacterial killing activity of macrophages in this
model of sepsis (16, 17). On the other hand, CLP failed to
induce IL-4 and IL-13 in the peritoneum at any time
checked in both WT and Stat62/2 mice. IL-10 was in-
creased in the peritoneum after CLP, but there was no sta-
tistical significance between WT and Stat62/2 mice (data not
shown). Thus, Stat62/2 mice showed an altered cytokine
profile in the peritoneum in favor of bacterial clearance.
CLP-initiated Organ Injury Was Ameliorated in Stat42/2
Mice. Sepsis frequently causes MOF, a condition that
leads to death (1, 2). To understand the mechanism
whereby Stat42/2 mice were resistant to CLP, experiments
were conducted to assess the organ damage induced by
CLP. The data in Fig. 6 show that CLP resulted in in-
creases in the serum level of AST, ALT, BUN, and creati-
nine in WT mice at 6 and 24 h after CLP, indicating that
CLP caused liver and kidney damage in WT mice. How-
ever, the levels of AST, ALT, BUN, and creatinine in
Stat42/2 mice after CLP were remarkably reduced com-
pared with WT mice, and the levels were comparable to
those in untreated mice (Fig. 6), suggesting that organ in-
jury was evaded in Stat42/2 mice. Histologically, CLP in-
duced a significant number of infiltrating neutrophils in the
liver in WT mice, which was dramatically reduced in
Stat42/2 mice (Fig. 7). Correspondingly, MPO level in the
liver, an indirect means of determining the recruitment of
neutrophils, was significantly decreased in Stat42/2 mice
compared with WT mice (Fig. 8). CLP also caused an ele-
vated level of MPO in the lung, which was decreased in
Stat42/2 mice although it was not statistically significant.
MPO level in the kidney was slightly increased in WT
mice after CLP, which was not altered in Stat42/2 mice
(Fig. 8). CLP did not cause any histological changes in the
kidney of WT and Stat42/2 mice (data not shown). Thus,
organ damage was ameliorated in Stat42/2 mice without
affecting the bacterial load in the peritoneum, which was
partly associated with decreased organ inflammation.
Organ-associated Cytokine Profile Was Altered in Stat42/2
Mice. We next measured organ-associated cytokine levels
in Stat42/2 mice. The level of IFN-g in the liver, lung, and
kidney in Stat42/2 mice was comparable to WT mice at
any time checked. There was no difference in the level of
IL-4 between WT and Stat42/2 mice (data not shown). In
contrast, the levels of type 2 cytokine IL-10 and IL-13 in
Stat42/2 mice were significantly augmented in the liver
compared with WT mice (Fig. 9). Conversely, MIP-2 level
in the liver of Stat42/2 mice was much lower than that in
WT mice. KC level in the liver was also decreased in
Stat42/2 mice, although it was not statistically significant
(Fig. 9). Similarly, the levels of MIP-2 and KC in the kid-
ney and lung of Stat42/2 mice were significantly decreased
Figure 5. Participation of elevated levels of TNF-a and IL-12 in the
neutrophil infiltration and bacterial clearance in Stat62/2 mice. Anti–
TNF-a, anti–IL-12, or control antibodies were intraperitoneally injected,
2 h before CLP. (A) At 6 h after CLP, mice were killed and the infiltrat-
ing leukocytes in the peritoneal cavity were counted. (B) 10 ml of perito-
neal fluids harvested at 24 h after CLP was serially diluted and plated on
TSA blood agar plates. Line represents median CFU count. Each point
represents the mean 6 SEM of seven estimations from separate mice.
†P , 0.05 compared with control.
Figure 6. Stat42/2 mice ameliorate organ
injury induced by CLP. At 6 and 24 h after
CLP, mice were killed, bled, and the sera
were harvested. The amounts of AST, ALT,
BUN, and creatinine in the sera were mea-
sured. The data represent the mean ± SEM
of 8–11 estimations from separate mice.
†P , 0.05, §P , 0.01,  ‡P , 0.001, *P ,
0.0001 compared with WT mice. Dotted
line, mean data obtained from untreated
mice (six mice each).684 Stat4 and Stat6 in Innate Immunity
compared with WT mice, although there were no differ-
ences in the level of IL-10 and IL-13 (Fig. 9). Thus, cyto-
kine profile in organs during sepsis was altered in Stat42/2
mice.
Systemic Inflammatory Response in Stat62/2 Mice. Sys-
temic inflammatory response in Stat62/2 mice was also in-
vestigated. Serum levels of AST, ALT, BUN, and creati-
nine in Stat62/2 mice were not significantly increased at 6
and 24 h after CLP compared with untreated Stat62/2
mice (Fig. 10 A). MPO level in the liver, lung, and kidney
at 24 h after CLP was decreased in Stat62/2 mice compared
with WT mice, although the level in the lung and kidney
was not statistically significant (Fig. 10 B). MIP-2 and KC
levels in Stat62/2 organs were significantly decreased com-
pared with WT mice, and comparable to untreated mice
(Fig. 10 C). These data suggest that more effective bacterial
clearance in the peritoneum may result in a reduction in
organ inflammation and damage.
Discussion
Recent studies using Stat42/2 mice have demonstrated
that the type 1 cytokine response mediated by Stat4 is criti-
cal for the protective immunity against Leishmania major
and Trypanosoma cruzi (21, 22). Others have shown using
Stat62/2 mice that type 2 cytokine response mediated by
Stat6 is necessary for the development of airway hyperre-
sponsiveness in allergen-induced airway inflammation (23,
24) and Schistosoma mansoni OVA-induced granuloma (25).
Thus, Stat42/2 and Stat62/2 mice appear to be an excellent
experimental system for analyzing the importance of type 1
and type 2 cytokine responses in vivo. We have recently
shown that IL-12 (type 1 promoting cytokine) and IL-13 (a
type 2 cytokine), both of which are endogenously pro-
duced during sepsis initiated by CLP, play beneficial roles
in CLP-induced sepsis by enhancing local bacteria clear-
ance and modulating systemic organ injury, respectively (9,
10). Since Stat4 and Stat6 are essential transcription factors
Figure 7. Histological alter-
ation in the liver after CLP. The
photograph are representative of
findings in the liver harvested at
24 h after CLP from WT and
Stat42/2 mice. There are few
neutrophils in the liver of Stat42/2
mice. Arrows indicate the infil-
trating neutrophils in the liver of
WT mice. Original magnifica-
tions: top, 3400; bottom,
31,000.
Figure 8. MPO level in organs in Stat42/2 mice af-
ter CLP. At 24 h after CLP, mice were killed, and the
liver, lung, and kidney were resected. The organs were
extracted and the amounts of MPO were measured.
The data represent the mean 6 SEM (WT, eight mice;
Stat42/2, eight mice). Dotted line, mean data obtained
from untreated tissues (six mice each). †P , 0.05 com-
pared with WT mice.685 Matsukawa et al.
that respond to IL-12 and IL-13, respectively, we had ini-
tially hypothesized that Stat42/2 and Stat62/2 mice would
be susceptible to septic peritonitis induced by CLP. In con-
trast to the hypothesis, the data clearly demonstrated that
Stat42/2 and Stat62/2 mice were resistant to the lethality
induced by CLP. In an attempt to understand these find-
ings, we found that bacterial clearance was enhanced in
Stat62/2 mice, whereas systemic organ damage initiated by
CLP was ameliorated in Stat42/2 mice without affecting
bacterial load in the peritoneum and peripheral blood.
Leukocytes play a crucial role in bacterial clearance (5).
To understand the enhanced bacterial clearance in Stat62/2
Figure 9. Cytokine levels in organs of Stat42/2 mice af-
ter CLP. At 24 h after CLP, mice were killed, bled, and
the liver, lung, and kidney were harvested. The protein
concentrations of IL-10, IL-13, MIP-2, and KC were
measured by ELISA. The data represent the mean 6 SEM
(WT, 10 mice; Stat42/2, 9 mice). †P , 0.05, §P , 0.01,
‡P , 0.001 compared with WT mice. Dotted line, mean
data obtained from untreated mice (six mice each).
Figure 10. Systemic inflammatory response in
Stat62/2 mice. (A) At 6 and 24 h after CLP, mice
were killed, bled, and the sera were harvested. The
amounts of AST, ALT, BUN, and creatinine in the
sera were measured. (B and C) The liver, lung, and
kidney were resected at 24 h after CLP, extracted,
and the levels of MPO (B) and MIP-2 and KC (C)
were measured. The data represent the mean 6
SEM (WT, 10 mice; Stat62/2, 11 mice). †P  ,
0.05, §P , 0.01, *P , 0.0001 compared with WT
mice. Dotted line, mean data obtained from un-
treated mice (six mice each).686 Stat4 and Stat6 in Innate Immunity
mice, lysozomal enzyme release and superoxide production
from leukocytes were examined in vitro, which showed
that the activation of leukocytes in itself was similar be-
tween Stat62/2 and WT mice, suggesting a possibility that
Stat62/2 mice cleared bacteria more effectively than WT
mice based on the situation of the cells. When cytokines
were measured in the peritoneum after CLP, levels of IL-
12 and TNF-a were significantly increased in Stat62/2
mice compared with WT mice. IL-12 and TNF-a have
been shown to enhance bacterial clearance in several bacte-
rial infection models including septic peritonitis (9, 26). In
this study, treatment of Stat62/2 mice with anti–IL-12 or
anti–TNF-a antibodies increased the bacterial load in the
peritoneum, indicating that elevated levels of these cyto-
kines contribute to the improved bacterial clearance in
Stat62/2 mice. TNF-a also contributed to the increase in
the number of infiltrating neutrophils, the cells that play a
crucial role in bacterial clearance (5). In addition, MDC
and C10 were elevated in Stat62/2 mice compared with
WT mice. These CC chemokines are generally regarded to
be associated with the type 2 response, as these chemokines
can be induced by IL-4 and IL-13 (27, 28) and both are in-
volved in the development of type 2–associated chronic in-
flammation (29, 30). However, we have recently demon-
strated that both MDC and C10 exhibit a strong type 1
response in innate immunity during septic peritonitis, as
these chemokines are capable of inducing macrophage acti-
vation and protect mice from CLP-induced lethality by en-
hancing bacterial clearance of macrophages (16, 17). Ex-
pression of MDC in macrophages is enhanced by TNF-a
and IL-1b (31). IL-1b induces C10 production from peri-
toneal macrophages and C10 stimulates TNF-a production
from macrophages in the presence of IL-1b (17). Thus,
MDC and C10 appear to be unique chemokines that play a
divergent role depending on the immune situation and
contributing cell types. It should be noted that IL-4 and IL-
13 were not detected in the peritoneum after CLP and T
cells were minor cell populations in the infiltrating leuko-
cytes in the peritoneum. Another type 2 cytokine, IL-10,
was detected in the peritoneum, but the level in WT mice
was similar to that in Stat62/2 mice. These findings suggest
that Stat62/2 mice were resistant to septic peritonitis by ex-
erting an improved bacterial clearance via an altered cyto-
kine profile in the peritoneum in favor of bacterial clear-
ance. However, unlike in vivo data, the levels of IL-12,
TNF-a, MDC, and C10 were not augmented when innate
immune cells from in Stat62/2 mice were stimulated with
LPS or E. coli (data not shown). Further study will be nec-
essary to understand the mechanism underlying the regula-
tion of cytokine production.
Sepsis frequently causes MOF, a fatal condition to the
host (1, 2). The liver is a major target organ, and the injury
generally arises from excessive hepatic inflammation (32,
33), which was significantly modulated in Stat42/2 mice
compared with WT mice. Interestingly, hepatic levels of
IL-10 and IL-13 in Stat42/2 mice were significantly higher
than those in WT mice. IL-10 and IL-13 are type 2 cyto-
kines that have antiinflammatory properties both in vitro
and in vivo (34) and have been shown to play a protective
role in this model of sepsis, by downregulating inflamma-
tory cytokines (10, 35). In Stat42/2 mice, hepatic levels of
MIP-2 and KC, CXC chemokines known to attract and
activate neutrophils, were markedly lower than those in WT
mice. These chemokines were also decreased in Stat42/2
lung, and there was a trend toward a decrease in the level
of MPO in Stat42/2 lung. The renal system is also a target
in sepsis, and the injury is likely to be caused by renal hy-
poperfusion, not by inflammation (36). This was partly
supported by our present data, as renal function was signifi-
cantly impaired in CLP mice without being accompanied
by a significant increase in the kidney level of MPO. Inter-
estingly, CLP-induced kidney injury was not observed in
Stat42/2 mice, and this was associated with a dramatic de-
crease in the kidney level of MIP-2 and KC in Stat42/2
mice while levels of IL-4, IL-10, and IL-13 were compara-
ble to those in WT mice. Thus, Stat42/2 kidney also
exhibited an altered cytokine balance in favor of antiin-
flammatory cytokine. Although the precise role of these
chemokines in the kidney is unclear, reduced production
of MIP-2 and KC in Stat42/2 mice may be responsible for
the improved kidney function.
Previous investigations have shown that T cells from
Stat42/2 mice impair type 1 response and exhibit enhanced
type 2 response (15, 37), whereas T cells from Stat62/2
mice lack type 2 response, intensifying type 1 response (14,
38, 39). A recent in vivo study has demonstrated that
Stat62/2 mice are resistant to infection against Leishmania
mexicana via developing type 1 cytokine response (40).
Thus, Stat62/2 mice exhibited an enhanced type 1 re-
sponse while Stat42/2 mice showed the inverse phenotype.
Our results are consistent with these findings, as Stat62/2
and Stat42/2 mice were resistant to CLP-induced sepsis by
enhancing local type 1 cytokine response and organ-associ-
ated type 2 cytokine response, respectively. Studies have
suggested that a shift from a type 1 to a type 2 cytokine re-
sponse contributes to the late immunosuppression seen
during sepsis (41, 42). However, in addition to an impor-
tance of the local type 1 cytokine response, the results in
this and our previous study (10) suggest the importance of
organ-associated type 2 cytokine response in host defense
during sepsis. It is possible that prevention of mortality in
Stat42/2 and Stat62/2 mice after CLP is because of inter-
ference with signal transduction of other cytokines that are
not measured or discussed in this study. However, it ap-
pears that the balance of type 1 and type 2 cytokine re-
sponses influences the outcome of sepsis and septic shock.
A very interesting observation in this study is that the
type 1/type 2 cytokine balance can be controlled for the
convenience of the host defense if one can regulate the ac-
tivation of Stat4 and Stat6 proteins at the right time in the
right place. The management of sepsis is largely supportive
and based on prevention and vigorous resuscitation includ-
ing early nutritional support and adequate oxygenation.
Sepsis remains a serious disorder and the mortality attribut-
able to sepsis and sepsis-mediated MOF has not signifi-
cantly improved over the past three decades (1, 2). Devel-687 Matsukawa et al.
opment of new drugs that specifically regulate Stat4 and
Stat6 activity may pave the way for novel therapeutic inter-
ventions in sepsis. Innate immune response is tightly linked
to acquired immune response (43). Augmenting the innate
responses by Stat proteins has the potential to deliver im-
mediate effects, as well as immunoregulatory functions pro-
moting the most beneficial downstream adaptive responses,
for defense against particular pathogens.
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